Dr. Hoke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 North Caroline Street
Baltimore, MD 21287Phone+1 410-955-9441Fax+1 410-955-6402
Education & Training
- University of AlbertaFellowship, 1997 - 1999
- Johns Hopkins UniversityResidency, Neurology, 1994 - 1997
- Case Western Reserve UniversityPhD, Neuroscience, 1989 - 1994
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1990 - 1992
- Hacettepe University FOMClass of 1988
Certifications & Licensure
- MD State Medical License 1994 - 2026
- OH State Medical License 1992 - 1994
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
Publications & Presentations
PubMed
- 98 citationsFracture repair requires TrkA signaling by skeletal sensory nerves.Zhu Li, Carolyn A. Meyers, Leslie Chang, Seungyong Lee, Zhi Li
The Journal of Clinical Investigation. 2019-12-02 - 39 citationsMonocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging.Mithilesh Kumar Jha, Youngjin Lee, Katelyn A. Russell, Fang Yang, Raha Dastgheyb
Glia. 2020-01-01 - 304 citationsThe Effect of the Alignment of Electrospun Fibrous Scaffolds on Schwann Cell MaturationSing Yian Chew, Ruifa Mi, Ahmet Hoke, Kam W. Leong
Biomaterials. 2008-02-01
Press Mentions
- Johns Hopkins Medicine Establishes Center Thanks to Gift from Merkin Family Foundation to Seek Better Understanding, Treatment of Damaging Nerve DisorderApril 7th, 2021
- Your Neurology Director Will See You Now…on ZoomSeptember 4th, 2020
- Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κBApril 9th, 2019
- Join now to see all
Grant Support
- The Foundation For Peripheral Neuropathy Research Symposium 2012National Institute Of Neurological Disorders And Stroke2012
- "Peripheral Nerve Society Biannual Meeting 2011"National Institute Of Neurological Disorders And Stroke2011
- Developmental CoreNational Institute Of Mental Health2011
- HIV And Antiretroviral Toxic NeuropathyNational Institute Of Neurological Disorders And Stroke2007–2011
- Mechanisms Of Glucose ToxicityNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Seahorse Xf-96 Analyzer For Non-Invasive Monitoring Of Mitochondrial FunctionNational Center For Research Resources2010
- Peripheral Neurotoxicity By The HIV-1 Coat Protein GP120National Institute Of Neurological Disorders And Stroke2006–2007
- An In Vitro Model Of Antiretroviral Toxic NeuropathyNational Institute Of Neurological Disorders And Stroke2002–2005
Professional Memberships
- Member
- American Neurological AssociationFellow
Other Languages
- Turkish
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/ahmet-hoke
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: